OppenheimerFunds’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $493K | Buy |
14,859
+2,034
| +16% | +$67.5K | ﹤0.01% | 1373 |
|
|
2018
Q4 | $373K | Buy |
12,825
+2,100
| +20% | +$61.1K | ﹤0.01% | 1484 |
|
|
2018
Q3 | $493K | Sell |
10,725
-1,579
| -13% | -$72.6K | ﹤0.01% | 1455 |
|
|
2018
Q2 | $460K | Sell |
12,304
-4,194
| -25% | -$157K | ﹤0.01% | 1457 |
|
|
2018
Q1 | $488K | Buy |
16,498
+60
| +0.4% | +$1.78K | ﹤0.01% | 1411 |
|
|
2017
Q4 | $564K | Sell |
16,438
-604
| -4% | -$20.7K | ﹤0.01% | 1450 |
|
|
2017
Q3 | $616K | Sell |
17,042
-8,133
| -32% | -$294K | ﹤0.01% | 1424 |
|
|
2017
Q2 | $651K | Sell |
25,175
-4,996
| -17% | -$129K | ﹤0.01% | 1379 |
|
|
2017
Q1 | $579K | Buy |
+30,171
| New | +$579K | ﹤0.01% | 1443 |
|